The global Next Generation Sequencing Market is expected to reach USD 19.70 billion by 2025 registering a CAGR of 12.78%, according to a new report by Grand View Research, Inc. Growing application of NGS methodologies due to rising number of strategic developments initiated by the market participants is one of the key drivers of the market. These novel strategies mark the presence of intense competition between the key firms. Companies are further increasing their installation base by providing sequencing services in different emerging countries. For instance, in April 2018, Illumina entered into a partnership with Loxo Oncology for the development of Illumina TruSight Tumor 170 NGS test as a companion diagnostic for Loxo Oncology’s LOXO-292 and larotrectinib for tumor profiling.
Similarly, in March 2018, PierianDx partnered with cancer genetics to offer NGS-based tests for oncology precision medicine. NGS technologies experience significant growth due to rapid automation in the pre-sequencing protocols and advancements in clinical diagnosis and disease testing. Wide application of this technique in oncology, reproductive screening, infectious disease, noninvasive prenatal testing, and pharmacogenomics is also expected to positively impact the market growth. Reduced costs of genetic sequencing has also significantly enhanced the adoption of these technologies. Reduced installation costs of NGS platforms and easy availability of proteomic and genomic data has also resulted in an increased demand, thereby propelling the market development.
Request a Sample Copy of the Global Next Generation Sequencing (NGS) Market Research Report @ https://www.grandviewresearch.com/industry-analysis/next-generation-sequencing-market/request/rs1
Further key findings from the study suggest:
Have Any Query? Ask Our Experts@ https://www.grandviewresearch.com/inquiry/1496/ibb
Grand View Research has segmented the global next generation sequencing market on the basis of products & services, application, technology, workflow, end use, and region:
NGS Products & Services Outlook (Revenue, USD Million, 2014 – 2025)
NGS Application Outlook (Revenue, USD Million, 2014 – 2025)
NGS Technology Outlook (Revenue, USD Million, 2014 – 2025)
NGS Workflow Outlook (Revenue, USD Million, 2014 – 2025)
NGS End Use Outlook (Revenue, USD Million, 2014 – 2025)
NGS Regional Outlook (Revenue, USD Million, 2014 – 2025)
Browse Related Category @
Neuroscience Market: The global neuroscience market size was valued at USD 28.42 billion in 2016 and is expected to grow at a Significant CAGR over the forecast period.
Orthobiologics Market: The industry is primarily driven by the increasing number of orthopedic procedures globally as a consequence of an upsurge in accidents and obesity.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: www.grandviewresearch.com/industry-analysis/next-generation-sequencing-market